Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
(CH3)3N+CH2COOH · Cl-
CAS Number:
Molecular Weight:
153.61
EC Number:
209-683-1
UNSPSC Code:
12352202
PubChem Substance ID:
Beilstein/REAXYS Number:
3916181
MDL number:
product line
BioUltra
assay
≥99%
impurities
≤0.0005% Phosphorus (P), ≤0.1% Insoluble matter
ign. residue
≤0.1%
mp
241-242 °C (lit.)
solubility
H2O: 1 M, clear, colorless
anion traces
sulfate (SO42-): ≤0.05%
cation traces
Al: ≤0.0005%, Ca: ≤0.0005%, Cu: ≤0.0005%, Fe: ≤0.0005%, K: ≤0.005%, Mg: ≤0.0005%, NH4+: ≤0.05%, Na: ≤0.05%, Pb: ≤0.001%, Zn: ≤0.0005%
SMILES string
[Cl-].C[N+](C)(C)CC(O)=O
InChI
1S/C5H11NO2.ClH/c1-6(2,3)4-5(7)8;/h4H2,1-3H3;1H
InChI key
HOPSCVCBEOCPJZ-UHFFFAOYSA-N
Biochem/physiol Actions
End-product of oxidative metabolism of choline, betaine is a general methyl donor, in particular in a minor pathway of methionine biosynthesis. It is used to treat homocystinuria, which is a defect in the major pathway of methionine biosynthesis.
Still not finding the right product?
Explore all of our products under Betaine hydrochloride
signalword
Danger
hcodes
Hazard Classifications
Eye Dam. 1
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Bernd C Schwahn et al.
The Biochemical journal, 382(Pt 3), 831-840 (2004-06-26)
MTHFR (methylenetetrahydrofolate reductase) catalyses the synthesis of 5-methyltetrahydrofolate, the folate derivative utilized in homocysteine remethylation to methionine. A severe deficiency of MTHFR results in hyperhomocysteinaemia and homocystinuria. Betaine supplementation has proven effective in ameliorating the biochemical abnormalities and the clinical
Jun Ying et al.
PloS one, 8(2), e54561-e54561 (2013-02-06)
Evidence from human and animal research indicates that choline metabolic pathways may be activated during a variety of diseases, including cancer. We report results of a case-control study of 2821 lung cancer cases and 2923 controls that assessed associations of
A mysterious case of dysphagia demystified by medication reconciliation.
Karthik Ragunathan et al.
The American journal of medicine, 126(6), e1-e1 (2013-05-21)
